Product image of Vortemyel (Bortezomib) supplied by GNH India

Vortemyel

Active Ingredient:
Bortezomib
Origin:
EU

Vortemyel (Bortezomib)

Vortemyel (Bortezomib) is a prescription medication used in cancer treatment, particularly for multiple myeloma and mantle cell lymphoma. This proteasome inhibitor is administered via injection, targeting cancer cells directly. Always consult a healthcare professional before use. Not for self-administration.

Manufacturer / TM Owner

Zentiva, K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Vortemyel (Bortezomib) is primarily used to treat certain types of cancer, including multiple myeloma and mantle cell lymphoma. It works by interfering with the growth of cancer cells, helping to slow or stop their spread. This medication is often part of a combination therapy regimen. Patients may wonder, 'what is Vortemyel used for' or 'how does bortezomib work in cancer treatment'.

Side Effects

  • Vortemyel (Bortezomib) may cause side effects such as nausea, fatigue, or reduced blood cell counts. Some patients experience peripheral neuropathy, which can include tingling or numbness in the hands or feet. These effects vary by individual and should be monitored by a healthcare provider.

Precautions & Warnings

  • Vortemyel (Bortezomib) should only be handled and administered by trained medical professionals. Patients with certain conditions, such as severe liver disease or neuropathy, may need special monitoring. Keep this medication refrigerated and protected from light until use. Always follow healthcare provider instructions for safe handling.

Avoid Interactions

  • Vortemyel (Bortezomib) may interact with other medications, including CYP3A4 inhibitors or inducers, which can affect its effectiveness. Alcohol and certain supplements may also interact, potentially increasing side effects. Patients should inform their healthcare provider about all medications and supplements they are taking.

Frequently Asked Questions

Vortemyel is used to treat multiple myeloma and mantle cell lymphoma by slowing the growth of cancer cells.

Vortemyel is given as an injection, either intravenously or subcutaneously, by a healthcare professional.

Common side effects may include nausea, fatigue, reduced blood cell counts, and peripheral neuropathy.

No, Vortemyel must be administered by a trained medical professional in a clinical setting.

Yes, it may interact with CYP3A4 inhibitors, inducers, alcohol, and certain supplements.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bortezomib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT